Etiketter

Summa sidvisningar

Leta i den här bloggen

torsdag 14 maj 2015

Insuliini ja keramidi- mitä koorelaatiota

Kasumov T, Solomon TP, Hwang C, Huang H, Haus JM, Zhang R, Kirwan JP.
Obesity (Silver Spring). 2015 May 12. doi: 10.1002/oby.21117. [Epub ahead of print]
PMID:
25966363
2.
Warshauer JT, Lopez X, Gordillo R, Hicks J, Holland WL, Anuwe E, Blankfard MB, Scherer PE, Lingvay I.
Diabetes Metab Res Rev. 2015 May 10. doi: 10.1002/dmrr.2662. [Epub ahead of print]
PMID:
25959529
3.
Romero-Guevara R, Cencetti F, Donati C, Bruni P.
Front Aging Neurosci. 2015 Apr 23;7:60. doi: 10.3389/fnagi.2015.00060. eCollection 2015. Review.
4.
Liu Y, Sen S, Wannaiampikul S, Palanivel R, Hoo RL, Isserlin R, Bader GD, Tungtrongchitr R, Deshaies Y, Xu A, Sweeney G.
Biochem J. 2015 Apr 27. [Epub ahead of print]
5.
Goldberg EL, Dixit VD.
Immunol Rev. 2015 May;265(1):63-74. doi: 10.1111/imr.12295.
PMID:
25879284
6.
Škop V, Malínská H, Trnovská J, Hüttl M, Cahová M, Blachnio-Zabielska A, Baranowski M, Burian M, Oliyarnyk O, Kazdová L.
PLoS One. 2015 Apr 1;10(4):e0122768. doi: 10.1371/journal.pone.0122768. eCollection 2015.
7.
Bellini L, Campana M, Mahfouz R, Carlier A, Véret J, Magnan C, Hajduch E, Le Stunff H.
Expert Opin Ther Targets. 2015 Mar 26:1-14. [Epub ahead of print]
PMID:
25814122
8.
Gao S, Duan C, Gao G, Wang X, Yang H.
Int J Biochem Cell Biol. 2015 Mar 23;64:25-33. doi: 10.1016/j.biocel.2015.03.006. [Epub ahead of print]
PMID:
25813876
9.
De la Maza MP, Rodriguez JM, Hirsch S, Leiva L, Barrera G, Bunout D.
J Nutr Health Aging. 2015;19(4):389-96. doi: 10.1007/s12603-014-0548-7. (Suom.  14.5. 2015)
PMID:
25809802
10.
Lee SY, Hong IK, Kim BR, Shim SM, Sung Lee J, Lee HY, Choi CS, Kim BK, Park TS.
Hepatology. 2015 Mar 22. doi: 10.1002/hep.27804. [Epub ahead of print]
PMID:
25808625
11.
Cai Y, Lydic TA, Turkette T, Reid GE, Olson LK.
Biochem Pharmacol. 2015 May 1;95(1):46-57. doi: 10.1016/j.bcp.2015.03.010. Epub 2015 Mar 20.
PMID:
25801003
12.
Dlamini Z, Ntlabati P, Mbita Z, Shoba-Zikhali L.
Exp Mol Pathol. 2015 Mar 18;98(3):574-584. doi: 10.1016/j.yexmp.2015.03.022. [Epub ahead of print]
PMID:
25794976
13.
Fillmore N, Keung W, Kelly SE, Proctor SD, Lopaschuk GD, Ussher JR.
Exp Physiol. 2015 Mar 19. doi: 10.1113/EP085052. [Epub ahead of print]
PMID:
25786668
14.
Midtbø LK, Borkowska AG, Bernhard A, Rønnevik AK, Lock EJ, Fitzgerald ML, Torstensen BE, Liaset B, Brattelid T, Pedersen TL, Newman JW, Kristiansen K, Madsen L.
J Nutr Biochem. 2015 Feb 4. pii: S0955-2863(15)00021-2. doi: 10.1016/j.jnutbio.2014.12.005. [Epub ahead of print]
15.
Obanda DN, Yu Y, Wang ZQ, Cefalu WT.
J Nutr Biochem. 2015 Mar 5. pii: S0955-2863(15)00040-6. doi: 10.1016/j.jnutbio.2015.01.007. [Epub ahead of print]
PMID:
25771159
16.
Garcia AM, Ladage ML, Dumesnil DR, Zaman K, Shulaev V, Azad RK, Padilla PA.
Genetics. 2015 May;200(1):167-84. doi: 10.1534/genetics.115.174631. Epub 2015 Mar 10.
PMID:
25762526
17.
Babenko NA, Kharchenko VS.
Biochemistry (Mosc). 2015 Jan;80(1):104-12. doi: 10.1134/S0006297915010125.
PMID:
25754045
18.
Bryndina IG, Shalagina MN, Ovechkin SV, Ovchinina NG.
Ross Fiziol Zh Im I M Sechenova. 2014 Nov;100(11):1280-6. Russian.
PMID:
25665406
19.
Konstantynowicz-Nowicka K, Harasim E, Baranowski M, Chabowski A.
PLoS One. 2015 Jan 30;10(1):e0116858. doi: 10.1371/journal.pone.0116858. eCollection 2015.
20.
Chua MW, Lin MZ, Martin JL, Baxter RC.
J Cell Commun Signal. 2015 Jan 25. [Epub ahead of print]
PMID:
25617051

torsdag 7 maj 2015

Rautatammenlehtiteen fenoliset antioksidantit

 Otan tämän luettelon glukoosiblogiin, koska tätä teetä on käytetty diabeteksen hoitoon  joissain kulttuureissa ja sillä on myös hyvät ominaisuudet pahojen  (PAH) lisäksi.  Tästä artikkelista herää ajatus, että  kasvin runsaita  orgaanisia fenolisia  antioksidantteja voitaisiin käyttää - haitta-aineista puhdistamisen jälkeen-  luonnonantioksidantteina synteettisten sijasta, jolloin tämä rautatammi katsottaisiin  raaka-aineeksi, josta voitaisiin saada niitä antioksidantimolekyylejä esiin. eikä niin että koko kasvia kaikkine osinensa seoksena suoraan käytettäisiin .http://www.sfcri.com/vilka-ar-farorna-med-yerba-mate-for-cancer/  Ei taida sopia suomalaiselle koska  voi vaihtaa päälle kansan perinnölliset maksasyöpägeenit, sillä geenisäätövaikutus on vahva.

Molecules 2007, 12(3), 423-432; doi:10.3390/12030423
Article Phenolic Antioxidants Identified by ESI-MS from Yerba Maté (Ilex paraguariensis) and Green Tea (Camelia sinensis) Extracts

Received: 21 December 2006 / Revised: 3 March 2007 / Accepted: 4 March 2007 / Published: 12 March 2007
(This article belongs to the Special Issue Phenolics and Polyphenolics)
Download PDF [160 KB, uploaded 18 June 2014]
Abstract
Aqueous extracts of green yerba maté (Ilex paraguariensis) and green tea (Camellia sinensis) are good sources of phenolic antioxidants, as already described in the literature. The subject of this study were organic extracts from yerba maté, both green and roasted, and from green tea. Their phenolic profiles were characterized by direct infusion electrospray insertion mass spectrometry (ESI-MS) and their free radical scavenging activity was determined by the DPPH assay.
 Organic extracts containing phenolic antioxidants might be used as natural antioxidants by the food industry, replacing the synthetic phenolic additives used nowadays.
 Ethanolic and aqueous extracts from green yerba maté, roasted yerba maté and green tea showed excellent DPPH scavenging activity (>89%). The ether extracts from green and roasted yerba maté displayed a weak scavenging activity, different from the behavior observed for the green tea ether extract. The main phenolic compounds identified in green yerba maté water and ethanolic extracts were:
caffeic acid, 
quinic acid,
 caffeoyl glucose,
 caffeoylquinic acid,
 feruloylquinic acid,
 dicaffeoylquinic acid
 and rutin.
 After the roasting process two new compounds were formed:
 caffeoylshikimic acid
 and dicaffeoylshikimic acid. 
The ethanolic extracts from yerba maté, both roasted and green, with lower content of phenolic compounds (3.80 and 2.83 mg/mL) presented high antioxidant activity and even at very low phenolic concentrations, ether extract from GT (0.07 mg/mL) inhibited DPPH over 90%.
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Rautatammiteen cancerogeenisyys johtuu polysyklisistä aromaatisista hiilivedyistä

 Mielestäni tätä teetä ei pitäisi käyttää  diabeteksen tasapainotukseen tai laihdutuslääkkeenä.Kuitenkin tämä on monessa maassa E-Amerikassa tavallinen kulttuurijuoma, joten suositukseni eivät yllä tästä pitemmälle. http://www.sfcri.com/vilka-ar-farorna-med-yerba-mate-for-cancer/

LÄHDE: Cancer Epidemiol Biomarkers Prev. 2008 May;17(5):1262-8. doi: 10.1158/1055-9965.EPI-08-0025.High levels of carcinogenic polycyclic aromatic hydrocarbons in mate drinks.

Abstract BACKGROUND:

Drinking mate has been associated with cancers of the esophagus, oropharynx, larynx, lung, kidney, and bladder. We conducted this study to determine whether drinking mate could lead to substantial exposure to polycyclic aromatic hydrocarbons (PAH), including known carcinogens, such as benzo[a]pyrene.

METHODS: The concentrations of 21 individual PAHs were measured in dry leaves of eight commercial brands of yerba mate and in infusions made with hot (80 degrees C) or cold (5 degrees C) water. Measurements were done using gas chromatography/mass spectrometry, with deuterated PAHs as the surrogates. Infusions were made by adding water to the leaves, removing the resulting infusion after 5 min, and then adding more water to the remaining leaves. This process was repeated 12 times for each infusion temperature.

RESULTS: The total concentrations of the 21 PAHs in different brands of yerba mate ranged from 536 to 2,906 ng/g dry leaves. Benzo[a]pyrene concentrations ranged from 8.03 to 53.3 ng/g dry leaves. For the mate infusions prepared using hot water and brand 1, 37% (1,092 of 2,906 ng) of the total measured PAHs and 50% (25.1 of 50 ng) of the benzo[a]pyrene content were released into the 12 infusions. Similar results were obtained for other hot and cold infusions.

CONCLUSION: Very high concentrations of carcinogenic PAHs were found in yerba mate leaves and in hot and cold mate infusions. Our results support the hypothesis that the carcinogenicity of mate may be related to its PAH content.

PMID:18483349 [PubMed - indexed for MEDLINE]
Free full text

Yerba Mate teen hyvistä puolista ( Ilex paraguariensis)

Tunnen  diabeetikoita, jotka käyuttävät Yerba mate teetä  verensokerin stabiloimiseen ja katson sen takia mitä tämä tee on. Se osoittautuu rautatammiperäiseksi kasvituotteeksi.
 Siitä on monta artikkelia PubMed tieteellisissä julkaisuissa kuten tämä:
 http://www.ncbi.nlm.nih.gov/pubmed/23670797
Siinä on katsottu fundamentaalinen signalointikohta aineenvaihdunnasta, joka  tapaa olla metabolisissa taudeissa  vikasäädössä.  (PI3K-AKT signalointi.
Asetan  artikkelin alle muitakin lähteitä, missä on tietoja signaalitievaikutuksista. 

Mol Nutr Food Res. 2013 Oct;57(10):1882-5. doi: 10.1002/mnfr.201200834. Epub 2013 May 14.Modulatory effects of yerba maté (Ilex paraguariensis) on the PI3K-AKT signaling pathway.

Abstract

The aim of this study was to evaluate the effects of yerba maté (YM) extract on the phosphatidylinositol 3-kinase (PI3K)-AKT signaling pathway in vivo. The mice were introduced to either standard- or high-fat diet (HFD). After 8 weeks on an HFD, mice were randomly assigned to one of the two treatment conditions, water or yerba maté extract at 1.0 g/kg. After treatment, glucose blood level and hepatic insulin response were evaluated. Liver tissue was examined to determine the mRNA levels using the PI3K-AKT PCR array. The nuclear translocation of forkhead box O1 (FOXO1) was determined by an electrophoretic mobility-shift assay. Our data demonstrated that yerba maté extract significantly decreased the final body weight, glucose blood levels, and insulin resistance of mice. Molecular analysis demonstrated that an HFD downregulated Akt2, Irs1, Irs2, Pi3kca, Pi3kcg, and Pdk1; after yerba maté treatment, the levels of those genes returned to baseline. In addition, an HFD upregulated Pepck and G6pc and increased FOXO1 nuclear translocation. The intervention downregulated these genes by decreasing FOXO1 nuclear translocation. The results obtained demonstrate for the first time the specific action of yerba maté on the PI3K-AKT pathway, which contributed to the observed improvement in hepatic insulin signaling.
© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

  • ADIPOGENEESIN SÄÄTELYGEENIT vaikuttuvat , kovin monta  monta geeniä vaikuttuu.
 http://www.ncbi.nlm.nih.gov/pubmed/25338179
  • LIIKAKÄYTÖN VAAROJA: 
Yerba mate -tee on oikeastaan aika pahanmakuinen, joten sen erittäin runsas käyttäminen eräissä kulttuureissa  johtuu  sen muista vaikutuksista eikä kielen tuntemasta mausta eikä  hyvästä teearomista, kuten tavallisella  mustalla teellä on. Tästä Yerba mate teestä tulee haljun vihreän väristä. Tyyppihaju on aika vahva, helposti tunnistettava jos kerran on sen tuoksun  tuntenut,  ja  aromi tarttuu koko huoneeseen.
Runsas tai pitkäaikainen  käyttö altistaa  ruokatorvien levyepiteelisyövälle , mikä on milteipä luonnollista koska on kyse   jostain tropiikin paksulehtisestä  kasvista. Saattaa olla että tämä tee on  hyvin dominoiva kulttuurijuoma, ja joskus  puun lehtiä  on käytetty nälkätilan ainoana   viherravintolähteenä, joten on mahdollista että toksisuus  paljastuu merkitsevänä. Lisäksi  tropiikin kansanlääkeaineet eivät tosiaan ole  apteekkitasoa.  Tällä on siellä maine  hyvänä  lääkkeenä diabeteksessa ja monessa muussa taudissa- mit´ltei kuin yleislääke. . Muitakin syöpiä se voi aiheuttaa, koska siinä on polysyklisiä aromaattisia hiilivetyjä (PAH); lisäksi kuuman teen aiheuttamia ovat  lämpövauriot.

 http://www.ncbi.nlm.nih.gov/pubmed/24130226

Cancer Epidemiol Biomarkers Prev. 2014 Jan;23(1):107-16. doi: 10.1158/1055-9965.EPI-13-0796. Epub 2013 Oct 15.

Maté drinking and esophageal squamous cell carcinoma in South America: pooled results from two large multicenter case-control studies.

Abstract

BACKGROUND:Maté tea is a nonalcoholic infusion widely consumed in southern South America, and may increase risk of esophageal squamous cell carcinoma (ESCC) and other cancers due to polycyclic aromatic hydrocarbons (PAH) and/or thermal injury.

METHODS: We pooled two case-control studies: a 1988 to 2005 Uruguay study and a 1986 to 1992 multinational study in Argentina, Brazil, Paraguay, and Uruguay, including 1,400 cases and 3,229 controls. We computed ORs and fitted a linear excess OR (EOR) model for cumulative maté consumption in liters/day-year (LPDY).

RESULTS: The adjusted OR for ESCC with 95% confidence interval (CI) by ever compared with never use of maté was 1.60 (1.2-2.2). ORs increased linearly with LPDY (test of nonlinearity; P = 0.69). The estimate of slope (EOR/LPDY) was 0.009 (0.005-0.014) and did not vary with daily intake, indicating maté intensity did not influence the strength of association. EOR/LPDY estimates for consumption at warm, hot, and very hot beverage temperatures were 0.004 (-0.002-0.013), 0.007 (0.003-0.013), and 0.016 (0.009-0.027), respectively, and differed significantly (P < 0.01). EOR/LPDY estimates were increased in younger (<65 alcohol="" and="" but="" by="" drinkers="" evaluations="" hoc="" homogeneous="" individuals="" never="" post="" sex.="" span="" these="" were="">

CONCLUSIONS: ORs for ESCC increased linearly with cumulative maté consumption and were unrelated to intensity, so greater daily consumption for shorter duration or lesser daily consumption for longer duration resulted in comparable ORs. The strength of association increased with higher maté temperatures.

IMPACT: Increased understanding of cancer risks with maté consumption enhances the understanding of the public health consequences given its purported health benefits.